GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Cadence Financial Corporation (CADE) [hlAlert]

Rating:
Buy CADE
down 86.34 %

Cadence Financial Corporation (CADE) rated Buy

Posted on: Tuesday,  Oct 2, 2007  11:25 AM ET by Stanford Research

Stanford Research rated Buy Cadence Financial Corporation (NASDAQ: CADE) on 10/02/2007, when the stock price was $18.24. Since
then, Cadence Financial Corporation has lost 86.35% as of 03/04/2011's recent price of $2.49.
If you would have followed this Stanford Research's recommendation on CADE, you would have lost 86.34% of your investment in 1249 days.

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.

Stanford Research encompasses both institutional equity research and Washington-focused policy research, offering a perspective on individual companies, sector-specific topics and national policy. The importance Stanford Group Company places on research comes from years of experience in a constantly changing world. We know that as markets develop and new sectors grow, it is imperative that our clients have the most accurate information available to ensure financial success. Stanford Group Company clients will always have our commitment to conduct informative and enlightening research. As a part of our commitment to our clients, we provide objective, well-developed research. Our skilled analysts use their talent to provide invaluable research that can help in making important decisions. Thanks to a wide range of resources obtained through technology, experience and reputation, our research analysts develop reports on the most current firms and sectors. Our equity analysts offer insight and opinions on companies in the consumer/retail, media, energy, financial institutions, health care, technology and water/environment sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/2/2007 11:25 AM Buy
None
18.24 23.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD down  -74.46 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy